Novel treatment dynamics for biofilm-related infections

References

• Del Pozo JL. Biofilm-related disease. Expert Rev Anti Infect Ther. 2018;16(1):51–65.
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther. 2007;82(2):204–209.
   PubMed Web of Science ®Google Scholar
• Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev. 2014;78(3):510–543.
   PubMed Web of Science ®Google Scholar
• Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358(9276):135–138.
   PubMed Web of Science ®Google Scholar
• Vuotto C, Donelli G. Novel treatment strategies for biofilm-based infections. Drugs. 2019;79(15):1635–1655.
   PubMed Web of Science ®Google Scholar
• Hoiby N, Bjarnsholt T, Givskov M, et al. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322–332.
   PubMed Web of Science ®Google Scholar
• Thaarup IC, Bjarnsholt T. Current in vitro Biofilm-infected chronic wound models for developing new treatment possibilities. Adv Wound Care (New Rochelle). 2020;10(2):91–102.
   PubMed Web of Science ®Google Scholar
• Trostrup H, Laulund ASB, Moser C. Insights into Host-pathogen interactions in Biofilm-infected wounds reveal possibilities for new treatment strategies. Antibiotics (Basel). 2020;9(7):7.
   Web of Science ®Google Scholar
• Del Pozo JL, Patel R. Are antibiotics and surgery sufficient to treat biofilm-associated infections? Enferm Infecc Microbiol Clin. 2013;31(10):641–642.
   PubMed Web of Science ®Google Scholar
• Escudero-Sanchez R, Senneville E, Digumber M, et al. Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study. Clin Microbiol Infect. 2020;26(4):499–505.
   PubMed Web of Science ®Google Scholar
• Hughes G, Webber MA. Novel approaches to the treatment of bacterial biofilm infections. Br J Pharmacol. 2017;174(14):2237–2246.
   PubMed Web of Science ®Google Scholar
• Romano CL, Scarponi S, Gallazzi E, et al. Antibacterial coating of implants in orthopaedics and trauma: a classification proposal in an evolving panorama. J Orthop Surg Res. 2015;10(1):157.
   PubMedGoogle Scholar
• Romano CL, Toscano M, Romano D, et al. Antibiofilm agents and implant-related infections in orthopaedics: where are we? J Chemother. 2013;25(2):67–80.
   PubMed Web of Science ®Google Scholar
• Gristina AG, Naylor P, Myrvik Q. Infections from biomaterials and implants: a race for the surface. Med Prog Technol. 1988;14(3–4):205–224.
   PubMedGoogle Scholar
• Palumbo FS, Bavuso Volpe A, Cusimano MG, et al. A polycarboxylic/amino functionalized hyaluronic acid derivative for the production of pH sensible hydrogels in the prevention of bacterial adhesion on biomedical surfaces. Int J Pharm. 2015;478(1):70–77.
   PubMedGoogle Scholar
• Dijk F, Westerhof M, Busscher HJ, et al. In vitro formation of oropharyngeal biofilms on silicone rubber treated with a palladium/tin salt mixture. J Biomed Mater Res. 2000;51(3):408–412.
   PubMed Web of Science ®Google Scholar
• Kamal GD, Pfaller MA, Rempe LE, et al. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. Jama. 1991;265(18):2364–2368.
   PubMed Web of Science ®Google Scholar
• Paredes J, Alonso-Arce M, Schmidt C, et al. Smart central venous port for early detection of bacterial biofilm related infections. Biomed Microdevices. 2014;16(3):365–374.
   PubMed Web of Science ®Google Scholar
• Paredes J, Becerro S, Arizti F, et al. Real time monitoring of the impedance characteristics of Staphylococcal bacterial biofilm cultures with a modified CDC reactor system. Biosens Bioelectron. 2012;38(1):226–232.
   PubMed Web of Science ®Google Scholar
• Howlin RP, Brayford MJ, Webb JS, et al. Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections. Antimicrob Agents Chemother. 2015;59(1):111–120.
   PubMed Web of Science ®Google Scholar
• Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350(14):1422–1429.
   PubMed Web of Science ®Google Scholar
• Lemire JA, Harrison JJ, Turner RJ. Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat Rev Microbiol. 2013;11(6):371–384.
   PubMed Web of Science ®Google Scholar
• Whitchurch CB, Tolker-Nielsen T, Ragas PC, et al. Extracellular DNA required for bacterial biofilm formation. Science. 2002;295(5559):1487.
   PubMed Web of Science ®Google Scholar
• Billings N, Birjiniuk A, Samad TS, et al. Material properties of biofilms-a review of methods for understanding permeability and mechanics. Rep Prog Phys. 2015;78(3):036601.
   PubMed Web of Science ®Google Scholar
• McDougald D, Rice SA, Barraud N, et al. Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat Rev Microbiol. 2011;10(1):39–50.
   PubMed Web of Science ®Google Scholar
• Ren Z, Cui T, Zeng J, et al. Molecule targeting glucosyltransferase inhibits streptococcus mutans biofilm formation and virulence. Antimicrob Agents Chemother. 2016;60(1):126–135.
   PubMed Web of Science ®Google Scholar
• Okshevsky M, Regina VR, Meyer RL. Extracellular DNA as a target for biofilm control. Curr Opin Biotechnol. 2015;33:73–80.
   PubMed Web of Science ®Google Scholar
• Manzenreiter R, Kienberger F, Marcos V, et al. Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy. J Cyst Fibros. 2012;11(2):84–92.
   PubMed Web of Science ®Google Scholar
• Tetz VV, Tetz GV. Effect of extracellular DNA destruction by DNase I on characteristics of forming biofilms. DNA Cell Biol. 2010;29(8):399–405.
   PubMed Web of Science ®Google Scholar
• Izano EA, Wang H, Ragunath C, et al. Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res. 2007;86(7):618–622.
   PubMed Web of Science ®Google Scholar
• Donelli G, Francolini I, Romoli D, et al. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother. 2007;51(8):2733–2740.
   PubMed Web of Science ®Google Scholar
• Darouiche RO, Mansouri MD, Gawande PV, et al. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination. J Antimicrob Chemother. 2009;64(1):88–93.
   PubMed Web of Science ®Google Scholar
• Kolodkin-Gal I, Romero D, Cao S, et al. D-amino acids trigger biofilm disassembly. Science. 2010;328(5978):627–629.
   PubMed Web of Science ®Google Scholar
• Hochbaum AI, Kolodkin-Gal I, Foulston L, et al. Inhibitory effects of D-amino acids on Staphylococcus aureus biofilm development. J Bacteriol. 2011;193(20):5616–5622.
   PubMed Web of Science ®Google Scholar
• Alkawash MA, Soothill JS, Schiller NL. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms. APMIS. 2006;114(2):131–138.
   PubMed Web of Science ®Google Scholar
• Alipour M, Suntres ZE, Omri A. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J Antimicrob Chemother. 2009;64(2):317–325.
   PubMed Web of Science ®Google Scholar
• Bayer AS, Park S, Ramos MC, et al. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa. Infect Immun. 1992;60(10):3979–3985.
   PubMed Web of Science ®Google Scholar
• Fleming D, Chahin L, Rumbaugh K. Glycoside hydrolases degrade polymicrobial bacterial biofilms in wounds. Antimicrob Agents Chemother. 2017;61(2):2.
   Web of Science ®Google Scholar
• Schmelcher M, Shen Y, Nelson DC, et al. Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection. J Antimicrob Chemother. 2015;70(5):1453–1465.
   PubMed Web of Science ®Google Scholar
• Park KH, Lee YM, Hong HL, et al. Persistent catheter-related Staphylococcus aureus bacteremia after catheter removal and initiation of antimicrobial therapy. PLoS One. 2012;7(10):e46389.
   PubMed Web of Science ®Google Scholar
• Teschler JK, Zamorano-Sanchez D, Utada AS, et al. Living in the matrix: assembly and control of Vibrio cholerae biofilms. Nat Rev Microbiol. 2015;13(5):255–268.
   PubMed Web of Science ®Google Scholar
• Yasuda H, Ajiki Y, Aoyama J, et al. Interaction between human polymorphonuclear leucocytes and bacteria released from in-vitro bacterial biofilm models. J Med Microbiol. 1994;41(5):359–367.
   PubMed Web of Science ®Google Scholar
• Hengzhuang W, Song Z, Ciofu O, et al. CF-5/20 Disruption of mucoid pseudomonas aeruginosa biofilm in a murine lung infection model. Antimicrob Agents Chemother. 2016;60(5):2620–2626.
   PubMed Web of Science ®Google Scholar
• Reffuveille F, Fuente-Nunez Cde L, Fairfull-Smith KE, et al. Potentiation of ciprofloxacin action against Gram-negative bacterial biofilms by a nitroxide. Pathog Dis. 2015;73(5):5.
   Web of Science ®Google Scholar
• Roizman D, Vidaillac C, Givskov M, et al. In vitro evaluation of biofilm dispersal as a therapeutic strategy to restore antimicrobial efficacy. Antimicrob Agents Chemother. 2017;61(10):10.
   Web of Science ®Google Scholar
• Fleming D, Rumbaugh KP. Approaches to dispersing medical biofilms. Microorganisms. 2017;5(2):2.
   Web of Science ®Google Scholar
• Nett JE, Cabezas-Olcoz J, Marchillo K, et al. Targeting fibronectin to disrupt in vivo candida albicans biofilms. Antimicrob Agents Chemother. 2016;60(5):3152–3155.
   PubMed Web of Science ®Google Scholar
• Spaulding CN, Klein RD, Ruer S, et al. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist. Nature. 2017;546(7659):528–532.
   PubMed Web of Science ®Google Scholar
• Irie Y, Parsek MR. Quorum sensing and microbial biofilms. Curr Top Microbiol Immunol. 2008;322:67–84.
   PubMed Web of Science ®Google Scholar
• Estrela AB, Abraham WR. Combining Biofilm-controlling compounds and antibiotics as a promising new way to control biofilm infections. Pharmaceuticals (Basel). 2010;3(5):1374–1393.
   PubMedGoogle Scholar
• Nadell CD, Xavier JB, Levin SA, et al. The evolution of quorum sensing in bacterial biofilms. PLoS Biol. 2008;6(1):e14.
   PubMed Web of Science ®Google Scholar
• Bjarnsholt T, Jensen PO, Rasmussen TB, et al. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology (Reading). 2005;151(Pt 12):3873–3880.
   PubMedGoogle Scholar
• Hoffmann N, Lee B, Hentzer M, et al. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother. 2007;51(10):3677–3687.
   PubMed Web of Science ®Google Scholar
• Wu H, Song Z, Hentzer M, et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J Antimicrob Chemother. 2004;53(6):1054–1061.
   PubMed Web of Science ®Google Scholar
• Lonn-Stensrud J, Landin MA, Benneche T, et al. Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections? J Antimicrob Chemother. 2009;63(2):309–316.
   PubMed Web of Science ®Google Scholar
• Wu H, Lee B, Yang L, et al. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation. FEMS Immunol Med Microbiol. 2011;62(1):49–56.
   PubMed Web of Science ®Google Scholar
• Cirioni O, Mocchegiani F, Cacciatore I, et al. Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection. Peptides. 2013;40:77–81.
   PubMed Web of Science ®Google Scholar
• Anderson JK, Huang JY, Wreden C, et al. Chemorepulsion from the Quorum Signal Autoinducer-2 promotes helicobacter pylori biofilm dispersal. mBio. 2015;6(4):e00379.
   PubMed Web of Science ®Google Scholar
• Romling U, Galperin MY, Gomelsky M. Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev. 2013;77(1):1–52.
   PubMed Web of Science ®Google Scholar
• Christensen LD, Van Gennip M, Rybtke MT, et al. Clearance of Pseudomonas aeruginosa foreign-body biofilm infections through reduction of the cyclic Di-GMP level in the bacteria. Infect Immun. 2013;81(8):2705–2713.
   PubMed Web of Science ®Google Scholar
• Barraud N, Kelso MJ, Rice SA, et al. Nitric oxide: a key mediator of biofilm dispersal with applications in infectious diseases. Curr Pharm Des. 2015;21(1):31–42.
   PubMed Web of Science ®Google Scholar
• Schleheck D, Barraud N, Klebensberger J, et al. Pseudomonas aeruginosa PAO1 preferentially grows as aggregates in liquid batch cultures and disperses upon starvation. PLoS One. 2009;4(5):e5513.
   PubMed Web of Science ®Google Scholar
• Barraud N, Storey MV, Moore ZP, et al. Nitric oxide-mediated dispersal in single- and multi-species biofilms of clinically and industrially relevant microorganisms. Microb Biotechnol. 2009;2(3):370–378.
   PubMed Web of Science ®Google Scholar
• Helaine S, Kugelberg E. Bacterial persisters: formation, eradication, and experimental systems. Trends Microbiol. 2014;22(7):417–424.
   PubMed Web of Science ®Google Scholar
• Conlon BP, Nakayasu ES, Fleck LE, et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 2013;503(7476):365–370.
   PubMed Web of Science ®Google Scholar
• Ayrapetyan M, Williams TC, Oliver JD. Bridging the gap between viable but non-culturable and antibiotic persistent bacteria. Trends Microbiol. 2015;23(1):7–13.
   PubMed Web of Science ®Google Scholar
• Lafleur MD, Qi Q, Lewis K. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother. 2010;54(1):39–44.
   PubMed Web of Science ®Google Scholar
• Mulcahy LR, Burns JL, Lory S, et al. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol. 2010;192(23):6191–6199.
   PubMed Web of Science ®Google Scholar
• Lewis K, Shan Y. Persister Awakening. Mol Cell. 2016;63(1):3–4.
   PubMed Web of Science ®Google Scholar
• Lewis K. Persister cells: molecular mechanisms related to antibiotic tolerance. Handb Exp Pharmacol. 2012;(211):121–133
   Google Scholar
• Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 2007;5(1):48–56.
   PubMed Web of Science ®Google Scholar
• Kwan BW, Valenta JA, Benedik MJ, et al. Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother. 2013;57(3):1468–1473.
   PubMed Web of Science ®Google Scholar
• Spoering AL, Vulic M, GlpD LK. PlsB participate in persister cell formation in Escherichia coli. J Bacteriol. 2006;188(14):5136–5144.
   PubMed Web of Science ®Google Scholar
• Keren I, Minami S, Rubin E, et al. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio. 2011;2(3):e00100–11.
   PubMed Web of Science ®Google Scholar
• Kwan BW, Chowdhury N, Wood TK. Combatting bacterial infections by killing persister cells with mitomycin C. Environ Microbiol. 2015;17(11):4406–4414.
   PubMed Web of Science ®Google Scholar
• Zheng J, Wu Y, Lin Z, et al. ClpP participates in stress tolerance, biofilm formation, antimicrobial tolerance, and virulence of Enterococcus faecalis. BMC Microbiol. 2020;20(1):30.
   PubMed Web of Science ®Google Scholar
• Wood TK, Knabel SJ, Kwan BW. Bacterial persister cell formation and dormancy. Appl Environ Microbiol. 2013;79(23):7116–7121.
   PubMed Web of Science ®Google Scholar
• Shi W, Zhang X, Jiang X, et al. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science. 2011;333(6049):1630–1632.
   PubMed Web of Science ®Google Scholar
• Allison KR, Brynildsen MP, Collins JJ. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature. 2011;473(7346):216–220.
   PubMed Web of Science ®Google Scholar
• Tinoco JM, Buttaro B, Zhang H, et al. Effect of a genetically engineered bacteriophage on Enterococcus faecalis biofilms. Arch Oral Biol. 2016;71:80–86.
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, Alonso M, Arciola CR, et al. Biotechnological war against biofilms. Could phages mean the end of device-related infections? Int J Artif Organs. 2007;30(9):805–812.
   PubMed Web of Science ®Google Scholar
• Pearl S, Gabay C, Kishony R, et al. Nongenetic individuality in the host-phage interaction. PLoS Biol. 2008;6(5):e120.
   PubMed Web of Science ®Google Scholar
• Pires DP, Melo L, Vilas Boas D, et al. Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Curr Opin Microbiol. 2017;39:48–56.
   PubMed Web of Science ®Google Scholar
• Carmody LA, Gill JJ, Summer EJ, Sajjan US, Gonzalez CF, Young RF, et al. Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection. J Infect Dis. 2010;201(2):264–271.
   PubMed Web of Science ®Google Scholar
• Debarbieux L, Leduc D, Maura D, et al. Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. J Infect Dis. 2010;201(7):1096–1104.
   PubMed Web of Science ®Google Scholar
• Waters EM, Neill DR, Kaman B, et al. Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa. Thorax. 2017;72(7):666–667.
   PubMed Web of Science ®Google Scholar
• Donlan RM. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 2009;17(2):66–72.
   PubMed Web of Science ®Google Scholar
• Brussow H. Bacteriophage-host interaction: from splendid isolation into a messy reality. Curr Opin Microbiol. 2013;16(4):500–506.
   PubMed Web of Science ®Google Scholar
• Szafranski SP, Winkel A, Stiesch M. The use of bacteriophages to biocontrol oral biofilms. J Biotechnol. 2017;250:29–44.
   PubMed Web of Science ®Google Scholar
• Maszewska A, Zygmunt M, Grzejdziak I, et al. Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections. J Appl Microbiol. 2018;125(5):1253–1265.
   PubMed Web of Science ®Google Scholar
• Forti F, Roach DR, Cafora M, et al. Design of a Broad-range bacteriophage cocktail that reduces pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob Agents Chemother. 2018;62(6):6.
   Web of Science ®Google Scholar
• Yilmaz C, Colak M, Yilmaz BC, et al. Bacteriophage therapy in implant-related infections: an experimental study. J Bone Joint Surg Am. 2013;95(2):117–125.
   PubMed Web of Science ®Google Scholar
• Ryan RP, Vorholter FJ, Potnis N, et al. Pathogenomics of Xanthomonas: understanding bacterium-plant interactions. Nat Rev Microbiol. 2011;9(5):344–355.
   PubMed Web of Science ®Google Scholar
• Lu M, Hansen EN. Hydrogen peroxide wound irrigation in orthopaedic surgery. J Bone Jt Infect. 2017;2(1):3–9.
   PubMedGoogle Scholar
• Abedon S. Phage therapy pharmacology: calculating phage dosing. Adv Appl Microbiol. 2011;77:1–40.
   PubMed Web of Science ®Google Scholar
• Bechinger B, Gorr SU. Antimicrobial peptides: mechanisms of action and resistance. J Dent Res. 2017;96(3):254–260.
   PubMed Web of Science ®Google Scholar
• Overhage J, Campisano A, Bains M, et al. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun. 2008;76(9):4176–4182.
   PubMed Web of Science ®Google Scholar
• Hell E, Giske CG, Nelson A, et al. Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett Appl Microbiol. 2010;50(2):211–215.
   PubMed Web of Science ®Google Scholar
• Belley A, McKay GA, Arhin FF, et al. Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing. Antimicrob Agents Chemother. 2010;54(12):5369–5371.
   PubMed Web of Science ®Google Scholar
• Scott RW, Tew GN. Mimics of host defense proteins; Strategies for translation to therapeutic applications. Curr Top Med Chem. 2017;17(5):576–589.
   PubMed Web of Science ®Google Scholar
• Eckert R, Brady KM, Greenberg EP, et al. Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob Agents Chemother. 2006;50(11):3833–3838.
   PubMed Web of Science ®Google Scholar
• De La Fuente-nunez C, Reffuveille F, Mansour SC, et al. D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. Chem Biol. 2015;22(2):196–205.
   PubMedGoogle Scholar
• Batoni G, Maisetta G, Esin S. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim Biophys Acta. 2016;1858(5):1044–1060.
   PubMed Web of Science ®Google Scholar
• Jones EA, McGillivary G, Bakaletz LO. Extracellular DNA within a nontypeable Haemophilus influenzae-induced biofilm binds human beta defensin-3 and reduces its antimicrobial activity. J Innate Immun. 2013;5(1):24–38.
   PubMed Web of Science ®Google Scholar
• Folkesson A, Haagensen JA, Zampaloni C, et al. Biofilm induced tolerance towards antimicrobial peptides. PLoS One. 2008;3(4):e1891.
   PubMed Web of Science ®Google Scholar
• Liu Y, Kamesh AC, Xiao Y, et al. Topical delivery of low-cost protein drug candidates made in chloroplasts for biofilm disruption and uptake by oral epithelial cells. Biomaterials. 2016;105:156–166.
   PubMed Web of Science ®Google Scholar
• Yoon BK, Jackman JA, Valle-Gonzalez ER, et al. Antibacterial free fatty acids and monoglycerides: biological activities, experimental testing, and therapeutic applications. Int J Mol Sci. 2018;19(4):4.
   Web of Science ®Google Scholar
• Sintim HO, Smith JA, Wang J, et al. Paradigm shift in discovering next-generation anti-infective agents: targeting quorum sensing, c-di-GMP signaling and biofilm formation in bacteria with small molecules. Future Med Chem. 2010;2(6):1005–1035.
   PubMed Web of Science ®Google Scholar
• Romero D, Aguilar C, Losick R, et al. Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proc Natl Acad Sci U S A. 2010;107(5):2230–2234.
   PubMed Web of Science ®Google Scholar
• Hirshfield IN, Terzulli S, O’Byrne C. Weak organic acids: a panoply of effects on bacteria. Sci Prog. 2003;86(Pt 4):245–269.
   PubMedGoogle Scholar
• Bjarnsholt T, Alhede M, Jensen PO, et al. Antibiofilm properties of acetic acid. Adv Wound Care (New Rochelle). 2015;4(7):363–372.
   PubMed Web of Science ®Google Scholar
• Halstead FD, Rauf M, Moiemen NS, et al. The antibacterial activity of acetic acid against biofilm-producing pathogens of relevance to burns patients. PLoS One. 2015;10(9):e0136190.
   PubMed Web of Science ®Google Scholar
• Nagoba BS, Selkar SP, Wadher BJ, et al. Acetic acid treatment of pseudomonal wound infections–a review. J Infect Public Health. 2013;6(6):410–415.
   PubMed Web of Science ®Google Scholar
• Getliffe K. The effect of acidic maintenance solutions on catheter longevity. Nurs Times. 2004;100(16):32–34.
   PubMedGoogle Scholar
• Grudzinski A, Agarwal A, Bhatnagar N, et al. Benefits and harms of citrate locking solutions for hemodialysis catheters: a systematic review and meta-analysis. Can J Kidney Health Dis. 2015;2:13.
   PubMedGoogle Scholar
• Ordinola-Zapata R, Bramante CM, Aprecio RM, et al. Biofilm removal by 6% sodium hypochlorite activated by different irrigation techniques. Int Endod J. 2014;47(7):659–666.
   PubMed Web of Science ®Google Scholar
• Liu H, Wei X, Ling J, et al. Biofilm formation capability of Enterococcus faecalis cells in starvation phase and its susceptibility to sodium hypochlorite. J Endod. 2010;36(4):630–635.
   PubMed Web of Science ®Google Scholar
• Saiman L. The use of macrolide antibiotics in patients with cystic fibrosis. Curr Opin Pulm Med. 2004;10(6):515–523.
   PubMed Web of Science ®Google Scholar
• Garrison AT, Abouelhassan Y, Kallifidas D, et al. Halogenated phenazines that potently eradicate biofilms, MRSA persister cells in non-biofilm cultures, and mycobacterium tuberculosis. Angew Chem Int Ed Engl. 2015;54(49):14819–14823.
   PubMed Web of Science ®Google Scholar
• Jennings MC, Ator LE, Paniak TJ, et al. Biofilm-eradicating properties of quaternary ammonium amphiphiles: simple mimics of antimicrobial peptides. Chembiochem. 2014;15(15):2211–2215.
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, Rouse MS, Patel R. Bioelectric effect and bacterial biofilms. A systematic review. Int J Artif Organs. 2008;31(9):786–795.
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, Rouse MS, Euba G, et al. The electricidal effect is active in an experimental model of Staphylococcus epidermidis chronic foreign body osteomyelitis. Antimicrob Agents Chemother. 2009;53(10):4064–4068.
   PubMed Web of Science ®Google Scholar
• He Y, Bi Y, Hua Y, et al. Ultrasound microbubble-mediated delivery of the siRNAs targeting MDR1 reduces drug resistance of yolk sac carcinoma L2 cells. J Exp Clin Cancer Res. 2011;30:104.
   PubMed Web of Science ®Google Scholar
• He W, Wang W, Zhou P, et al. Enhanced ablation of high intensity focused ultrasound with microbubbles: an experimental study on rabbit hepatic VX2 tumors. Cardiovasc Intervent Radiol. 2011;34(5):1050–1057.
   PubMed Web of Science ®Google Scholar
• Blenkinsopp SA, Khoury AE, Costerton JW. Electrical enhancement of biocide efficacy against Pseudomonas aeruginosa biofilms. Appl Environ Microbiol. 1992;58(11):3770–3773.
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, Rouse MS, Euba G, et al. Prevention of Staphylococcus epidermidis biofilm formation using electrical current. J Appl Biomater Funct Mater. 2014;12(2):81–83.
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, Rouse MS, Mandrekar JN, et al. Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother. 2009;53(1):35–40.
   PubMed Web of Science ®Google Scholar
• Sperandio FF, Huang YY, Hamblin MR. Antimicrobial photodynamic therapy to kill Gram-negative bacteria. Recent Pat Antiinfect Drug Discov. 2013;8(2):108–120.
   PubMedGoogle Scholar
• Halstead FD, Thwaite JE, Burt R, et al. Antibacterial activity of blue light against nosocomial wound pathogens growing planktonically and as mature biofilms. Appl Environ Microbiol. 2016;82(13):4006–4016.
   PubMed Web of Science ®Google Scholar
• Gliosca LA, Stoppani N, Lamas NS, et al. Validation of an adherence assay to detect group mutans streptococci in saliva samples. Acta Odontol Latinoam. 2019;32(2):97–102.
   PubMedGoogle Scholar
• Plaetzer K, Krammer B, Berlanda J, et al. Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers Med Sci. 2009;24(2):259–268.
   PubMed Web of Science ®Google Scholar
• Lima FL, Joazeiro PP, Lancellotti M, et al. Effects of hyperbaric oxygen on Pseudomonas aeruginosa susceptibility to imipenem and macrophages. Future Microbiol. 2015;10(2):179–189.
   PubMed Web of Science ®Google Scholar
• Cimsit M, Uzun G, Yildiz S. Hyperbaric oxygen therapy as an anti-infective agent. Expert Rev Anti Infect Ther. 2009;7(8):1015–1026.
   PubMed Web of Science ®Google Scholar
• Baek YW, An YJ. Microbial toxicity of metal oxide nanoparticles (CuO, NiO, ZnO, and Sb2O3) to Escherichia coli, Bacillus subtilis, and Streptococcus aureus. Sci Total Environ. 2011;409(8):1603–1608.
   PubMed Web of Science ®Google Scholar
• Maira-Litran T, Kropec A, Goldmann DA, et al. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2005;73(10):6752–6762.
   PubMed Web of Science ®Google Scholar
• DiGiandomenico A, Warrener P, Hamilton M, et al. Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening. J Exp Med. 2012;209(7):1273–1287.
   PubMed Web of Science ®Google Scholar
• Jorgensen B, Karlsmark T, Vogensen H, et al. A pilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive-free, platelet-rich fibrin for the treatment of recalcitrant chronic wounds. Int J Low Extrem Wounds. 2011;10(4):218–223.
   PubMed Web of Science ®Google Scholar
• Thomsen K, Trostrup H, Christophersen L, et al. The phagocytic fitness of leucopatches may impact the healing of chronic wounds. Clin Exp Immunol. 2016;184(3):368–377.
   PubMed Web of Science ®Google Scholar
• Novotny LA, Brockman KL, Mokrzan EM, et al. Biofilm biology and vaccine strategies for otitis media due to nontypeable Haemophilus influenzae. J Pediatr Infect Dis. 2019;14(2):69–77.
   PubMed Web of Science ®Google Scholar
• Resch A, Leicht S, Saric M, et al. Comparative proteome analysis of Staphylococcus aureus biofilm and planktonic cells and correlation with transcriptome profiling. Proteomics. 2006;6(6):1867–1877.
   PubMed Web of Science ®Google Scholar
• Harro JM, Peters BM, O’May GA, et al. Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. FEMS Immunol Med Microbiol. 2010;59(3):306–323.
   PubMed Web of Science ®Google Scholar